Some examples and use cases from the internet:

Some examples and use cases from the internet:

• recognise immediately in profit or loss any excess remaining after that reassessment.
• An increase to a dose greater than the recommended starting dose is advised only after appropriate clinical reassessment and should generally occur at intervals of not less than 24 hours.
• Before adopting its decision, the competent national authority shall notify the right holder of its reassessment of the restrictions, indicating the extent of the right after reassessment, and shall allow him a reasonable time limit to withdraw his application.
• An increase to a dose greater than the recommended starting dose is advised only after appropriate clinical reassessment and should generally occur at intervals of not less than 24 hours.
• Transfusion of cryoprecipitate, fresh frozen plasma, and platelets should be considered with clinical and laboratory reassessment after each administration.
• It is important to set up a procedure whereby, in the event of refusal, agencies can submit themselves for reassessment after they have made the necessary improvements.
• Transfusions of cryoprecipitate, fibrinogen, fresh frozen plasma and platelets should be considered with clinical and laboratory reassessment after each administration.
• Dosage adjustment, if indicated, should occur only after clinical reassessment.

• An increase to a dose greater than the recommended starting dose is advised only after appropriate clinical reassessment and should generally occur at intervals of not less than 24 hours.
• Dosage adjustment, if indicated, should occur only after clinical reassessment.
• Has the EFSA notified it of its conclusions after its reassessment of the risks of this substance?
• Transfusions of cryoprecipitate, fibrinogen, fresh frozen plasma and platelets should be considered with clinical and laboratory reassessment after each administration.
• It is important to set up a procedure whereby, in the event of refusal, agencies can submit themselves for reassessment after they have made the necessary improvements.
• Transfusion of cryoprecipitate, fresh frozen plasma, and platelets should be considered with clinical and laboratory reassessment after each administration.
• Before adopting its decision, the competent national authority shall notify the right holder of its reassessment of the restrictions, indicating the extent of the right after reassessment, and shall allow him a reasonable time limit to withdraw his application.
• recognise immediately in profit or loss any excess remaining after that reassessment.